I agree that this site is using cookies. You can find further informations here.
X
Doubre, Helene
117  results:
Search for persons X
?
1

A prospective analysis of the management practices for pati..:

Jacob, Mathilde ; Fournel, Pierre ; Tissot, Claire...
Lung Cancer.  194 (2024)  - p. 107868 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Plasma tissue factor activity in lung cancer patients predi..:

Doubre, Helene ; Monnet, Isabelle ; Azarian, Reza...
Research and Practice in Thrombosis and Haemostasis.  8 (2024)  2 - p. 102359 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Real-World Treatment Outcomes of MET Exon14 Skipping in Non..:

Babey, Hélène ; Jamme, Philippe ; Curcio, Hubert...
Targeted Oncology.  18 (2023)  4 - p. 585-591 , 2023
Link: https://doi.org/10.1007/..
 
?
4

Clinical Characteristics of Patients with Advanced ALK-Tran..:

Dhamelincourt, Estelle ; Descourt, Renaud ; Rousseau-Bussac, Gaelle...
Targeted Oncology.  18 (2023)  6 - p. 905-914 , 2023
Link: https://doi.org/10.1007/..
 
?
5

Atezolizumab with or without bevacizumab and platinum-pemet..:

Bylicki, Olivier ; Tomasini, Pascale ; Radj, Gervais...
European Journal of Cancer.  183 (2023)  - p. 38-48 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Venous thrombotic events and impact on outcomes in patients..:

Doubre, Hélène ; Greillier, Laurent ; Justeau, Grégoire...
Journal of Cancer Research and Clinical Oncology.  149 (2023)  16 - p. 15095-15102 , 2023
Link: https://doi.org/10.1007/..
 
?
7

First-line single-agent pembrolizumab for PD-L1-positive (t..:

Descourt, Renaud ; Greillier, Laurent ; Perol, Maurice...
Cancer Immunology, Immunotherapy.  72 (2022)  1 - p. 91-99 , 2022
Link: https://doi.org/10.1007/..
 
?
8

Lorlatinib for advanced anaplastic lymphoma kinase–positive..:

Baldacci, Simon ; Besse, Benjamin ; Avrillon, Virginie...
European Journal of Cancer.  166 (2022)  - p. 51-59 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Discontinuation of immune checkpoint inhibitor (ICI) above ..:

Bilger, Geoffroy ; Girard, Nicolas ; Doubre, Hélène...
Cancer Immunology, Immunotherapy.  , 2021
Link: https://doi.org/10.1007/..
 
?
10

ALK Rearrangement in Lung Neuroendocrine Neoplasms: Case Se..:

Doubre, Helene ; Fraboulet, Severine ; Longchampt, Elisabeth...
Clinical Lung Cancer.  22 (2021)  5 - p. e686-e690 , 2021
Link: https://doi.org/10.1016/..
 
?
11

Efficacy and safety of programmed cell-death-protein-1 and ..:

Bylicki, Olivier ; Guisier, Florian ; Monnet, Isabelle...
Medicine.  99 (2020)  3 - p. e18726 , 2020
Link: https://doi.org/10.1097/..
 
?
12

Durable responses to immunotherapy of non-small cell lung c..:

Mayenga, Marie ; Assié, Jean-Baptiste ; Monnet, Isabelle...
Lung Cancer.  150 (2020)  - p. 21-25 , 2020
Link: https://doi.org/10.1016/..
 
?
13

PD-L1-expression patterns in large-cell neuroendocrine carc..:

Arpin, Dominique ; Charpentier, Marie-Christine ; Bernardi, Marie...
Therapeutic Advances in Medical Oncology.  12 (2020)  - p. 175883592093797 , 2020
Link: https://doi.org/10.1177/..
 
?
14

Efficacy and Safety of Anti–PD-1 Immunotherapy in Patients ..:

Guisier, Florian ; Dubos-Arvis, Catherine ; Viñas, Florent...
Journal of Thoracic Oncology.  15 (2020)  4 - p. 628-636 , 2020
Link: https://doi.org/10.1016/..
 
?
15

Non-Small Cell Lung Cancer Patients Harboring HER2 Mutation..:

Auliac, Jean-Bernard ; Dô, Pascal ; Bayle, Sophie...
Advances in Therapy.  36 (2019)  8 - p. 2161-2166 , 2019
Link: https://doi.org/10.1007/..
 
1-15